BioCardia
BCDA | NASDAQ
$0.79
-$0.04 (-4.93%)
At close: Nov 16, 2026, 4:00 PM ET
$0.81
+$0.02 (+3.16%)
After-hours:
Nov 16, 2026, 7:43 PM ET
-4.93%
(1D)No price chart data available for 1D timeframe.
Rating
35.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #649/1021 (Top 64%)
Key Statistics
Market Data
Market Cap $11.96M
1D Range
0.75 0.85
52W Range
0.75 1.47
Valuation (TTM)
PE -1.23
PB 14.32
EV/EBITDA -1.37
Valuation (NTM)
Forward PE N/A
Forward PEG 0.03
Price Target $25.00
Cash Flow
FCF Yield -63.7%
SBC Adj. FCF Yield -67.3%
SBC Impact -5.6%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-81.9%
Dil EPS 3Y | 5Y 76.8% |
50.3%
FCF 3Y | 5Y -2.1% |
10.9%
Returns
ROA -249.8%
ROE -912.4%
ROIC -552.6%
Financial Health
Net Cash
$2.22M
Current Ratio 1.11
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respir...
Sector Healthcare
Industry Biotechnology
Employees 17
IPO Date Nov 13, 1996
Website www.biocardia.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$25.00
Upside
+3064.56%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BCDA